Industry Update: Biotechnology
VRC is proud to release its latest industry report. The report provides a concise, insightful update on the Biotechnology industry including recent transactions, market multiples, company performance and purchase price allocation percentages.
I
ndustry Highlights
- On September 14, 2021, Sanofi announced the completion of its $3.2 billion acquisition of Translate Bio, further accelerating the company’s efforts to develop transformative vaccines and therapies using mRNA technology. With the acquisition, Translate Bio will continue as a surviving corporation and work as an indirect, fully owned unit of Sanofi.
- On July 21, 2021, AstraZeneca completed the $46 billion acquisition of Alexion Pharmaceuticals, Inc. AstraZeneca now has an enhanced scientific presence in immunology and, through Alexion’s innovative complement-biology platform and robust pipeline, will continue to pioneer the discovery and development of medicines for patients with rare diseases.
